291 related articles for article (PubMed ID: 29549840)
1. Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Sankaranarayanan M
Eur J Med Chem; 2018 Apr; 150():559-566. PubMed ID: 29549840
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Prakash Singh R; Jha PN; Sankaranarayanan M
Bioorg Chem; 2019 Mar; 84():98-105. PubMed ID: 30500524
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-leishmanial evaluation of 1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline derivatives against Leishmania infantum.
Ashok P; Chander S; Tejería A; García-Calvo L; Balaña-Fouce R; Murugesan S
Eur J Med Chem; 2016 Nov; 123():814-821. PubMed ID: 27541264
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in-vitro anti-leishmanial activity of (4-arylpiperazin-1-yl)(1-(thiophen-2-yl)-9H-pyrido[3,4-b]indol-3-yl)methanone derivatives.
Ashok P; Chander S; Chow LM; Wong IL; Singh RP; Jha PN; Sankaranarayanan M
Bioorg Chem; 2017 Feb; 70():100-106. PubMed ID: 27939960
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of 1,3,6-trisubstituted β-carboline derivatives for cytotoxic and anti-leishmanial potential.
Lunagariya NA; Gohil VM; Kushwah V; Neelagiri S; Jain S; Singh S; Bhutani KK
Bioorg Med Chem Lett; 2016 Feb; 26(3):789-794. PubMed ID: 26791014
[TBL] [Abstract][Full Text] [Related]
6. Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship.
Fan Y; Lu Y; Chen X; Tekwani B; Li XC; Shen Y
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400596
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis of new β-carboline derivatives and their selective anti-HIV-2 activity.
Ashok P; Chander S; Balzarini J; Pannecouque C; Murugesan S
Bioorg Med Chem Lett; 2015 Mar; 25(6):1232-5. PubMed ID: 25682562
[TBL] [Abstract][Full Text] [Related]
8. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
Kumar A; Katiyar SB; Gupta S; Chauhan PM
Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
[TBL] [Abstract][Full Text] [Related]
10. First Total Synthesis of ω-Phenyl Δ6 Fatty Acids and their Leishmanicidal and Anticancer Properties.
Carballeira NM; Morales-Guzman C; Alvarez-Benedicto E; Torres-Martinez Z; Delgado Y; Griebenow KH; Tinoco AD; Reguera RM; Perez-Pertejo Y; Carbajo-Andres R; Balana-Fouce R
Curr Top Med Chem; 2018; 18(5):418-427. PubMed ID: 29766807
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Paloque L; Hutter S; Castera-Ducros C; Laget M; Rault S; Valentin A; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2015 May; 23(10):2377-86. PubMed ID: 25846065
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-leishmanial activity of 1-aryl-β-carboline derivatives against Leishmania donovani.
Gohil VM; Brahmbhatt KG; Loiseau PM; Bhutani KK
Bioorg Med Chem Lett; 2012 Jun; 22(12):3905-7. PubMed ID: 22608390
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
18. Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners.
Huang TL; Vanden Eynde JJ; Mayence A; Donkor IO; Khan SI; Tekwani BL
J Pharm Pharmacol; 2006 Aug; 58(8):1033-42. PubMed ID: 16872549
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of amino-substituted 1H-phenalen-1-ones as anti-leishmanial agents.
Freijo MB; López-Arencibia A; Piñero JE; McNaughton-Smith G; Abad-Grillo T
Eur J Med Chem; 2018 Jan; 143():1312-1324. PubMed ID: 29126735
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
